Accelerating Science: How to cure the incurable with cell and gene therapy

GPCR Libraries by Twist Bioscience

Manufacturer Twist Bioscience  |   Model: genetic engineering,
Twist Biopharma, a division of Twist Bioscience, provides services to help accelerate the way our partners discover and optimize antibody therapeutics with our unique DNA writing technology. Twist constructs proprietary antibody libraries precisely designed to match sequences that occur in the human body giving our partners an integral and unbiased resource for antibody therapeutic discovery and optimization.

GPCR Libraries by Twist Bioscience product image
GPCR Libraries
Request Pricing

Receive your quote directly from the manufacturer.

0 Scientists have reviewed this product

Write the First Review

No Reviews

> 100,000 Different GPCR Binding Motifs

With over 100,000 different GPCR binding motifs, unlock the discovery of antibodies to this difficult-to-target class.

  • 30-50% of current drug targets are GPCRs but there are only 2 FDA approved antibodies
  • Current antibody drug development methods do not work
  • Random mutagenesis libraries are too inefficient to explore the effective sequence space


  • No immunization required
  • Synthetic mAb libraries focus on effective sequence space
  • Simultaneous screening against multiple targets